Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Bowel sterilisation; Gastrointestinal infections Age: Adult |
Dose: Oral – 1.5-3 million international units Frequency: three times daily Note: As colistin sulfate |
|
Indication: Bowel sterilisation; Gastrointestinal infections Age: Child |
Dose: Oral – 0.75-1.5 million international units Frequency: three times daily Note: As colistin sulfate |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Oral Susceptible Infections Age: less than 12 years old |
Dose: Oral – dosage expressed in terms of colistin base Note: Safety and efficacy not established |
|
Indication: Bowel sterilisation; Gastrointestinal infections Age: Child |
Dose: Oral (as colistin sulfate) Note: Not suitable |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment with Creatinine Clearance greater than 80 mL/minute |
Dose: Intravenous or Intramuscular – No dosage adjustment required Note: Renal Impairment CrCl greater than 80 mL/min: No dosage adjustment required |
|
Condition: Renal Impairment with Creatinine Clearance 50-79 mL/minute |
Dose: Intravenous or Intramuscular – 2.5-3.8 mg/kg/day Frequency: divided every 12 hours Note: Renal Impairment CrCl 50-79 mL/min: 2.5-3.8 mg/kg/day intravenous/intramuscular divided every 12 hours |
Administration
- Must be reconstituted before use
- For IV or IM use only
Side Effect
- Dizziness
- Paresthesia
- tingling sensation
- Neurotoxicity
- Nephrotoxicity
- Acute respiratory failure (inhalation route)
- Respiratory tract paralysis
- Acute tubular necrosis
- neurotoxicity
- nephrotoxicity
- when associated with use of curariform muscle relaxants
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Chloramphenicol, trimethoprim
|
Potentiates
|
|
Curariform Muscle Relaxants (Baclofen, Cyclobenzaprine, Tizanidine, Dantrolene)
|
Potentially Fatal: Potentiates action
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Anuria
|
Risk of drug toxicity
|
|
Porphyria
|
Risk of acute attacks
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Before reconstitution: Store below 30°C. After reconstitution: Store at 2°C to 8°C (Do not freeze) and use within 24 hours.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.